|
Index of reports
> Cases with Foetal Growth Restriction (9)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Tenormin (Atenolol) where reactions include foetal growth restriction. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Tenormin side effects in female
Reported by a physician from Japan on 2012-08-27
Patient: female
Reactions: Bradycardia Foetal, Foetal Growth Restriction, Foetal Exposure During Pregnancy, Long QT Syndrome Congenital
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tenormin
Start date: 2010-10-01
End date: 2011-01-01
Tenormin
Start date: 2011-01-01
Tenormin
End date: 2010-10-01
Possible Tenormin side effects in
Reported by a physician from Japan on 2012-07-16
Patient:
Reactions: Foetal Growth Restriction, Bradycardia Foetal, Foetal Exposure During Pregnancy, Long QT Syndrome Congenital
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tenormin
Tenormin
Possible Tenormin side effects in
Reported by a physician from Japan on 2012-07-05
Patient:
Reactions: Bradycardia Foetal, Foetal Growth Restriction, Foetal Exposure During Pregnancy, Long QT Syndrome Congenital
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Tenormin
Possible Tenormin side effects in female
Reported by a physician from Japan on 2012-06-21
Patient: female, weighing 1.0 kg (2.2 pounds)
Reactions: LOW Birth Weight Baby, Foetal Growth Restriction, Neonatal Respiratory Distress Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amlodipine Besylate
Candesartan Cilexetil
Hydralazine Hydrochloride
Hydralazine Hydrochloride
Nifedipine
Prednisolone
Tenormin
Possible Tenormin side effects in male
Reported by a physician from France on 2012-05-25
Patient: male, weighing 1.4 kg (3.1 pounds)
Reactions: Foetal Growth Restriction, Hypoglycaemia Neonatal, Ultrasound Doppler Abnormal, Neonatal Respiratory Distress Syndrome, Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cordarone
Start date: 2011-10-01
Cordarone
Indication: Hypertrophic Cardiomyopathy
Start date: 2011-06-15
End date: 2011-08-20
Tenormin
Indication: Hypertrophic Cardiomyopathy
Start date: 2011-06-15
Possible Tenormin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: male
Reactions: LOW Birth Weight Baby, Foetal Growth Restriction, Hypoglycaemia Neonatal, Neonatal Respiratory Distress Syndrome, Maternal Exposure Timing Unspecified, Foetal Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cordarone
Dosage: 200 mg/day
Indication: Hypertrophic Cardiomyopathy
End date: 2011-08-20
Cordarone
Dosage: 200 mg, unk
Start date: 2011-10-01
Tenormin
Dosage: 50 mg, twice daily
Indication: Hypertrophic Cardiomyopathy
Possible Tenormin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-09
Patient: male
Reactions: Foetal Growth Restriction, Maternal Exposure During Pregnancy
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Cordarone
Dosage: 200 mg, daily
Indication: Hypertrophic Cardiomyopathy
Lovenox
Dosage: 8000 iu, 2x/day
Indication: Hypertrophic Cardiomyopathy
Tenormin
Dosage: 100 mg, daily
Indication: Hypertrophic Cardiomyopathy
Other drugs received by patient: Celestone
Possible Tenormin side effects in male
Reported by a physician from France on 2012-01-09
Patient: male, weighing 0.6 kg (1.3 pounds)
Reactions: Foetal Growth Restriction, Premature Baby
Adverse event resulted in: death
Drug(s) suspected as cause:
Cordarone
Indication: Hypertrophic Cardiomyopathy
Lovenox
Indication: Hypertrophic Cardiomyopathy
Tenormin
Indication: Hypertrophic Cardiomyopathy
Other drugs received by patient: Celestone
Possible Tenormin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-04
Patient: male
Reactions: Foetal Growth Restriction, Maternal Exposure During Pregnancy
Adverse event resulted in: death, disablity
Drug(s) suspected as cause:
Cordarone
Indication: Hypertrophic Cardiomyopathy
Lovenox
Indication: Hypertrophic Cardiomyopathy
Tenormin
Indication: Hypertrophic Cardiomyopathy
Other drugs received by patient: Celestone
|
